Prevalence of colistin resistance in clinical isolates of Acinetobacter baumannii: a systematic review and meta-analysis
Open Access
- 28 February 2024
- journal article
- review article
- Published by Springer Nature in Antimicrobial Resistance & Infection Control
- Vol. 13 (1) , 1-17
Abstract
Introduction: The development of colistin resistance in Acinetobacter baumannii during treatment has been identified in certain patients, often leading to prolonged or recurrent infections. As colistin, is the last line of therapy for A. baumannii infections that are resistant to almost all other antibiotics, colistin-resistant A. baumannii strains currently represent a significant public health threat, particularly in healthcare settings where there is significant selective pressure. Aim: The aim of this study was to comprehensively determine the prevalence of colistin resistance in A. baumannii from clinical samples. Regional differences in these rates were also investigated using subgroup analyses. Method: The comprehensive search was conducted using “Acinetobacter baumannii”, “Colistin resistant” and all relevant keywords. A systematic literature search was performed after searching in PubMed, Embase, Web of Science, and Scopus databases up to April 25, 2023. Statistical analysis was performed using Stata software version 17 and sources of heterogeneity were evaluated using I2. The potential for publication bias was explored using Egger's tests. A total of 30,307 articles were retrieved. After a thorough evaluation, 734 studies were finally eligible for inclusion in the present systematic review and meta-analysis. Result: According to the results, the prevalence of resistance to colistin among A. baumannii isolates was 4% (95% CI 3–5%), which has increased significantly from 2% before 2011 to 5% after 2012. South America had the highest resistance rate to this antibiotic. The broth microdilution method had the highest level of resistance, while the agar dilution showed the lowest level. Conclusions: This meta-analysis found a low prevalence of colistin resistance among A. baumannii isolates responsible for infections worldwide from 2000 to 2023. However, there is a high prevalence of colistin-resistant isolates in certain countries. This implies an urgent public health threat, as colistin is one of the last antibiotics available for the treatment of infections caused by XDR strains of A. baumannii.Keywords
This publication has 23 references indexed in Scilit:
- Multidrug-resistant Acinetobacter baumannii as an emerging concern in hospitalsMolecular Biology Reports, 2021
- Quality assessment of prevalence studies: a systematic reviewJournal of Clinical Epidemiology, 2020
- Is it time to move away from polymyxins?: evidence and alternativesEuropean Journal of Clinical Microbiology & Infectious Diseases, 2020
- Colistin heteroresistance in Acinetobacter spp.: systematic review and meta-analysis of the prevalence and discussion of the mechanisms and potential therapeutic implicationsInternational Journal of Antimicrobial Agents, 2020
- A systematic review of implications, mechanisms, and stability of in vivo emergent resistance to colistin and tigecycline in Acinetobacter baumanniiJournal of Chemotherapy, 2020
- Rate of polymyxin resistance among Acinetobacter baumannii recovered from hospitalized patients: a systematic review and meta-analysisEuropean Journal of Clinical Microbiology & Infectious Diseases, 2020
- Global prevalence of colistin resistance in clinical isolates of Acinetobacter baumannii: A systematic review and meta-analysisMicrobial Pathogenesis, 2020
- Analysis of global prevalence of antibiotic resistance in Acinetobacter baumannii infections disclosed a faster increase in OECD countriesEmerging Microbes & Infections, 2018
- Chromosomally encoded and plasmid-mediated polymyxins resistance in Acinetobacter baumannii: a huge public health threatEuropean Journal of Clinical Microbiology & Infectious Diseases, 2018
- Secular trends in Acinetobacter baumannii resistance in respiratory and blood stream specimens in the United States, 2003 to 2012: A survey studyJournal of Hospital Medicine, 2015